IGLON5 and glycogen storage disease VI: Surprisingly, in-line with a recently published study [13] we show here that rather than hyperexcitability impairment of glutamatergic signalling and excitability can be seen in anti-IgLON5 disease 7 days after the neuron-antibody contact suggesting that hyper- and hypoexcitability can occur at different stages of disease.